MANTOVANI, GIOVANNI
MANTOVANI, GIOVANNI
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy
2017-01-01 CADEDDU DESSALVI, Christian; Piras, Alessandra; Dessi', Mariele; Madeddu, Clelia; Mantovani, Giovanni; Scartozzi, Mario; Hagendorff, Andreas; Colonna, Paolo; Mercuro, Giuseppe
Advances in pharmacologic strategies for cancer cachexia
2015-01-01 Madeddu, Clelia; Mantovani, Giovanni; Gramignano, G; Macciò, A.
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches
2015-01-01 Madeddu, Clelia; Mantovani, Giovanni; Gramignano, Giulia; Astara, Giorgio; Macciò, Antonio
The cachexia score (CASCO) as a tool for staging cachectic cancer patients
2014-01-01 Madeddu, Clelia; Serpe, Roberto; Busquets, S; Antoni, Giorgia; Betancourt, A; Gabba, S; Lopez Soriano, F; Maccio', A; Mantovani, Giovanni; Argiles, J.
The nutritional risk in oncology: a study of 1,453 cancer outpatients
2012-01-01 Bozzetti, F; Mariani, L; Lo Vullo, S; Amerio, Ml; Biffi, R; Caccialanza, R; Capuano, G; Correja, I; Cozzaglio, L; Di Leo, A; Di Cosmo, L; Finocchiaro, C; Gavazzi, C; Giannoni, A; Magnanini, P; Mantovani, G; Pellegrini, M; Rovera, Gm; Rovera, L; Sandri, G; Tinivella, M; Vigevani, E; Massa, E
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia
2010-01-01 Madeddu, Clelia; Macciò, Antonio; Astara, G; Massa, Elena; Dessì, M; Antoni, Giorgia; Panzone, F; Serpe, Roberto; Mantovani, Giovanni
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
2009-01-01 Rabaglio, M; Sun, Z; Price, Kn; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, Jf; Paridaens, Rj; Colleoni, M; Pienkowski, T; Nogaret, Jm; Láng, I; Smith, I; Gelber, Rd; Goldhirsch, A; Coates, As; Mantovani, G; Massa, E; on behalf of BIG 1-98 Collaborative and International Breast Cancer Study, Groups.
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer
2009-01-01 Giobbie-Hurder, A; Price, Kn; Gelber, Rd; Mantovani, G; Massa, E; on behalf of International Breast Cancer Study, Group; BIG 1-98 Collaborative Group. Clin Trials., 2009 Jun; 6(3):272-87,
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
2009-01-01 Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, Jf; Price, Kn; Regan, Mm; Gelber, Rd; Coates, As; Mantovani, G; Massa, E; on behalf of BIG 1-98 Collaborative, Group
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response
2009-01-01 Massa, Elena; Astara, G; Madeddu, Clelia; Dessi, M; Loi, C; Lepori, S; Mantovani, G.
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS)
2009-01-01 Madeddu C, Maccio A; Antoni, Giorgia; Cau MC, Massa E; Mantovani, Giovanni
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients
2009-01-01 Bozzetti, F; Mantovani, G; Massa, E; Madeddu, C; ON BEHALF OF THE SCRINIO, Group
An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: Background and design of an ongoing, phase III, randomized clinical trial
2007-01-01 Mantovani, G.; Madeddu, C.; Gramignano, G.; Serpe, R.; Massa, E.; Deiana, L.; Maccio, A.
A phase II study with antioxidants, both in the diet an supplemented, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia-cachexia and oxidative stress
2006-01-01 Mantovani, G; Madeddu, Clelia; Macciò, A; Gramignano, G; Lusso, Mr; Massa, E; Astara, G; Serpe, R.
Anorexia/Cachexia and oxidative stress in cancer patients = Anoressia/Cachessia e stress ossidativo nei pazienti con cancro
2003-01-01 Mantovani, G; Macciò, A; Madeddu, Clelia; Mura, L; Massa, E; Astara, G; Gramignano, G; Lusso, Mr; Murgia, V; Camboni, P; Ferreli, L.
Efficacy, compliance and prognostic significance of a comprehensive geriatric assessment in the geriatric cancer patient = Efficacia, applicabilità e significato prognostico di una valutazione geriatrica multidimensionale nel paziente oncologico anziano
2003-01-01 Mantovani, G; Massa, Elena; Ferreli, L; Astara, G; Madeddu, Clelia; Gramignano, G; Lusso, M. R.
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs
2003-01-01 Mantovani, G; Massa, Elena; Astara, G; Murgia, V; Gramignano, G; Lusso, Mr; Camboni, P; Ferreli, L; Mocci, M; Perboni, S; Mura, L; Madeddu, Clelia; Macciò, A.
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes
2003-01-01 Mantovani, G; Massa, Elena; Astara, G; Murgia, V; Gramignano, G; Ferreli, L; Camboni, P; Lusso, Mr; Mocci, M; Madeddu, Clelia; Mura, L; Mudu, Mc; Proto, E; Tore, G; Mura, M; Maccio', A; Ferreli, A; Amichetti, M.
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters
2003-01-01 Mantovani, G; Madeddu, Clelia; Gramignano, G; Lusso, Mr; Mocci, M; Massa, Elena; Ferreli, L; Astara, G; Macciò, A; Serpe, R.
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer
2002-01-01 Mantovani, G; Macciò, A; Mulas, C; Massa, Elena; Madeddu, Clelia; Mura, L; Contu, Paolo; Versace, R.